ArticleBiomolecules2024

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.

Chun-Ming Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.